CA918066A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
CA918066A
CA918066A CA105180A CA105180A CA918066A CA 918066 A CA918066 A CA 918066A CA 105180 A CA105180 A CA 105180A CA 105180 A CA105180 A CA 105180A CA 918066 A CA918066 A CA 918066A
Authority
CA
Canada
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA105180A
Inventor
Janssen Hans-Jochen
Hunger Alfred
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of CA918066A publication Critical patent/CA918066A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
CA105180A 1970-02-17 1971-02-12 Pharmaceutical preparations Expired CA918066A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH228070 1970-02-17
CH1461570 1970-10-02

Publications (1)

Publication Number Publication Date
CA918066A true CA918066A (en) 1973-01-02

Family

ID=25689996

Family Applications (1)

Application Number Title Priority Date Filing Date
CA105180A Expired CA918066A (en) 1970-02-17 1971-02-12 Pharmaceutical preparations

Country Status (7)

Country Link
AU (1) AU2548271A (en)
CA (1) CA918066A (en)
DE (1) DE2106071A1 (en)
FR (1) FR2081518A1 (en)
GB (1) GB1315450A (en)
IE (1) IE34941B1 (en)
NL (1) NL7102054A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents

Also Published As

Publication number Publication date
IE34941L (en) 1971-08-17
GB1315450A (en) 1973-05-02
DE2106071A1 (en) 1971-10-07
IE34941B1 (en) 1975-10-01
AU2548271A (en) 1972-08-17
NL7102054A (en) 1971-08-19
FR2081518A1 (en) 1971-12-03

Similar Documents

Publication Publication Date Title
AU472690B2 (en) New pharmaceutical preparations
AU456174B2 (en) Pharmaceutical preparation
AU3628971A (en) New pharmaceutical preparations
AU4470172A (en) Pharmaceutical compound preparations
AU3701671A (en) Pharmaceutical formulations
AU3017971A (en) Pharmaceutical composition
AU4864272A (en) New pharmaceutical preparations
CA918066A (en) Pharmaceutical preparations
AU464325B2 (en) New pharmaceutical preparations
AU3041671A (en) Pharmaceutical preparation
AU458023B2 (en) Pharmaceutical preparations
AU447332B2 (en) Pharmaceutical preparations
AU2932471A (en) Pharmaceutical preparations
AU1075770A (en) Therapeutic preparations
ZA71609B (en) New pharmaceutical preparations
AU4470372A (en) Pharmaceutical preparations
CA855186A (en) Pharmaceutical preparation
CA921826A (en) Pharmaceutical preparations
CA826629A (en) Pharmaceutical preparations
AU449731B2 (en) Pharmaceutical preparations
CA812214A (en) Pharmaceutical preparations
AU428829B2 (en) Pharmaceutical preparations
AU441388B2 (en) Pharmaceutical preparations
AU456248B2 (en) Oral preparations
AU3474771A (en) Pharmaceutical preparations